Greg Lovins
Analyst · Robert W. Baird & Co. Your line is now open
Thanks and hello, everybody. As Mitch said, we delivered another solid quarter with adjusted earnings per share of $1.66, up 14% despite the currency headwind. We grew sales by 2.1% on an organic basis, and currency translations reduced reported sales growth by two points in the quarter, and our adjusted operating margin increased by a full point to 11.7%. We realized $18 million of restructuring savings net of transition costs in the quarter due in part to LGM's restructuring in Europe that was largely completed as of the end of Q2 and our cash generation has been strong. We've delivered $327 million of free cash flow year-to-date up $67 million compared to the same period last year. As we've discussed, we've increased our pace of fix capital in IT-related spending for a few years to support our long-term organic growth and margin expansion plans. With capital spending expected to be up by about $20 million this year and we continue to return cash to shareholders. In the first three quarters of the year, we repurchase roughly 2 million shares at an aggregate cost of $204 million and paid $141 million in dividends, for a total of $346 million in cash return to shareholders. Importantly, our balance sheet remains strong, with net debt to adjust EBITDA kicking down slightly in the quarter. Our current leverage position gives us ample capacity to continue executing our disciplined capital allocation strategy, including investing in organic growth and acquisitions, while continuing to return to shareholders. We are well positioned to take advantage of any dislocations in the market should they occur over the next few years. Turning to the segment results for the quarter. Label and Graphic Materials sales increased by 1.2% on an organic basis, driven primarily by higher volume, as we've now left, the bulk of last year's price increases. Growth in LGM's high value categories led by specialty labels, continue to outpace the growth of the based business. And breaking down LGM's organic growth in the quarter by region, North America was roughly flat, while Western Europe was up low single-digits. Emerging markets also grew at a low single-digit rate with China up low single-digits in South Asia up mid single-digits. Adjusted operating margin for the segment was strong at 13.5%, up 120 basis points compared to the prior year, reflecting the benefit of productivity initiatives, including restructuring and material reengineering, partially offset by higher employee related costs. The net effect of changes in price and raw materials and freight input costs was neutral for the quarter. Shifting now to Retail Branding and Information Solutions, RBIS delivered solid top line growth of 4.1% on an organic basis, driven by faster growth and high value categories, with RFID's sales up roughly 28% and external embellishments growing even faster. Our based business adjusted for the migration of products to higher value RFID solutions was down low single-digits. Adjusted operating margin for the segment increased 10 basis points to 11.5%. As productivity gains were largely offset by long-term growth related investments primarily related to RFID. Turning to the Industrial and Healthcare Materials segment. Sales are up 3.7% on an organic basis, reflecting both volume growth and higher prices. Sales for industrial categories were up low to mid single digits, driven by solid growth in auto related categories. And healthcare categories grew even faster, up high single digits with medical up in the high teens. We made excellent progress on the margin front in IHM. Adjusted operating margin increased by 180 basis points to 11%. As a benefit from higher volume and productivity more than offset higher employee related costs. The normal seasonality does call for sequential easing in margin for the fourth quarter, I am confident we will exceed the 10% we targeted for IHM for the full year. Focusing now on our outlook for 2019. We've lowered the high end of our guidance range for adjusted earnings per share, reflecting incremental currency translation headwinds, largely offset by stronger operational results in a modestly lower tax rate compared to our previous expectations. We have reduced our outlook for full year organic sales growth to a range of 2.0% to 2.3%, which implies 2% to 3% growth for the fourth quarter. As you know in our short cycle businesses, visibility to demand is very limited and we've seen increased variability in order patterns from month-to-month. So, the lower end of our organic growth outlook assumes a continuation of the 2% we've seen year-to-date including the first few weeks of October. On the high-end reflects the fact that comparison to do easier for us over the balance of the quarter. We've outlined some of the other key contributing factor to our guidance on Slide 9 of over supplemental presentation materials. In particular and just focusing on the material changes from our assumptions in July, at recent exchange rates, currency translation represents a roughly 3.5% headwind to reported sales growth for the year with a pretax operating income hit of $37 million, an incremental $9 million headwind relative to the 28 million we were anticipating in July. Partially offsetting this, we now estimate the incremental pretax savings from restructuring, net of transaction costs will contribute approximately $50 million. As the teams have been executing very well against our plans, we look to deliver at the high-end of our previous expectations. We realized about $35 million of these savings in the first three quarters of the year. And a tax rate should come in slightly lower than our previous outlook, which I assumed 25% at the midpoint of our guidance range. In summary, we delivered another solid quarter in a more challenging environment and we remain on track to deliver on our long-term objectives to achieve GDP plus growth in top quartile return on capital, which together drive sustained growth EVA. And now we will open up the call for your questions.